The setup heading into D-Wave Quantum's November 10 earnings report is mixed-to-bearish on price action, yet structurally interesting: the stock is deeply oversold, sitting just $0.57 above its 20-day technical low, while 15 of 17 covering analysts maintain Buy or Strong Buy ratings and a mean price target of $33.84 — implying the market is pricing in prolonged skepticism that the street has not yet abandoned.
The Setup: A 39% Slide From the October Peak
QBTS closed Friday's session at $9.05, down 12.81% on the day — the latest leg of a sharp drawdown that has taken the stock from a recent 20-day high of $14.86 (October 9) to a session low of $8.48 on November 5, a decline of roughly 39% in under four weeks. The 5-day trend is DOWN, the 20-day trend is DOWN (–37.9% over the period), and the 100-day trend registers as a strong downtrend with the stock sitting below two standard deviations from its 100-day mean — a signal the trendline framework classifies as "extreme oversold."
Wednesday's broad quantum-sector selloff — in which QBTS, Rigetti (RGTI), and IonQ (IONQ) each fell roughly 8% with no company-specific news — accelerated the decline, underscoring how tightly these names trade as a risk-on/risk-off basket. The 100-day downtrend channel puts support at $8.48 (the recent floor) and resistance far above at $17.57. Within the nearer 20-day window, the range is narrower: support $8.48, resistance $11.09.
D-Wave did release a noteworthy product update this week: a major performance upgrade to its Stride hybrid solver, along with a new Applied Quantum Optimization learning path aimed at enterprise adoption. The practical relevance of that announcement for the upcoming quarterly print is limited, but it signals management is continuing to push commercial readiness ahead of the report.
What the Options Market Says
Dealer positioning tells a clear story about where market makers expect the stock to be magnetized around earnings. The call wall sits at the $10 strike (58,413 contracts of open interest) and the put wall at $9 (36,653 contracts), bracketing the current price at $9.05 in a tight $1 corridor. These levels represent the highest concentrations of dealer gamma — price tends to gravitate toward these strikes as expiration approaches, and any sustained move outside the corridor would force dealer re-hedging that amplifies the directional move.
Pre-earnings options positioning shows a notable asymmetry: the largest open interest build on the put side has concentrated at the $12 strike (18,566 contracts added), while call-side accumulation sits at the $20 strike (9,813 contracts). The put build at $12 is now well above the current stock price, meaning those contracts are deep in-the-money — suggesting that some positioning was established when the stock traded higher, and that protection demand has been active throughout the drawdown rather than being a fresh earnings-event bet.
The options flow score stands at 72/100, yet the flow signal reads as "distribution" with a bearish MACD signal. The RSI sits at an extremely depressed 22.5, well into oversold territory, while the 20-day SMA is at $11.73 and the 50-day SMA at $14.72 — both well above the current price, confirming the degree of technical damage. The options confidence model rates the current posture as BUY_PUTS with medium confidence and an overall signal score of 37/100.
Fundamentals & Estimates
D-Wave is a pre-profit company at an early commercialization stage, so the quarterly EPS number itself is less meaningful than revenue trajectory and customer pipeline. For the quarter ending this month (Q3 2026), the consensus of 16 analysts calls for:
- EPS: –$0.10 (range: –$0.13 to –$0.07), versus –$0.05 in the year-ago period — a wider loss year-over-year
- Revenue: ~$4.34 million (range: $3.23M to $7.0M), up roughly 16% year-over-year from $3.74M
Revenue growth at 16% YoY is positive but the absolute dollar levels remain small for a $3.9 billion market-cap company. The full-year 2026 consensus sits at $42.5M in revenue (up 73% YoY), which assumes a dramatic acceleration in later quarters — most notably a consensus +1Q (next quarter) estimate of $32.2 million, more than seven times the current-quarter estimate. That implies analysts are modeling a substantial contract or milestone event in Q4 2026 or Q1 2027 that is not yet announced.
Revision momentum is marginally positive: over the last 30 days, analysts have submitted 8 upward EPS revisions versus 7 downward, a net +1. This is a neutral-to-slightly-constructive signal — the consensus is not deteriorating, but conviction in upgrades is not strong either. The trailing EPS (TTM) is –$0.69, the ROE is –28%, and there is no dividend. The mean street price target of $33.84 (median $35.00, high $43.00) implies +274% upside from Friday's close — a spread between street expectations and market price that reflects either a deep undervaluation or significant skepticism about the commercialization timeline.
The bear case is straightforward: if Q3 revenue comes in at or below the low-end estimate of $3.23M and management provides no clear visibility on the step-change implied in Q4 estimates, the stock has limited technical support below $8.48. A break of that level would take QBTS into uncharted 20-day territory with no nearby trendline floor until the $7 range.
Key Levels to Watch
| Level | Price | Significance |
|---|---|---|
| Call Wall / Near Resistance | $10.00 | Highest call OI concentration (58,413 contracts); 20-day resistance |
| Current Price | $9.05 | Friday's close; pinned between put and call walls |
| Put Wall / Near Support | $9.00 | Highest put OI concentration (36,653 contracts); immediate floor |
| Recent Session Low | $8.48 | 20-day and 100-day technical support; breach signals further downside |
| 20-Day Resistance | $11.09 | Upper bound of near-term range; first meaningful hurdle on a rally |
| 100-Day Resistance | $17.57 | Long-term channel top; would require a material re-rating catalyst |
| Street Mean Price Target | $33.84 | Analyst consensus — reflects long-term bull case, not near-term range |
Bottom Line
D-Wave heads into its November 10 print in poor technical shape — deeply oversold, in a confirmed downtrend across all measured timeframes, and trading at a fraction of analyst price targets. The fundamental story has not broken: 15 of 17 analysts remain bullish, revenue growth is tracking positive YoY, and the Stride solver upgrade this week adds a product narrative. But the quarterly revenue number at roughly $4.3 million is small relative to the company's $3.9 billion valuation, and the really consequential estimates — the $32M+ quarters analysts are modeling for 2027 — are not yet provable from a single print.
For investors already holding QBTS, the $9.00 put wall and $8.48 technical floor define the near-term risk boundary. If the stock holds above $9.00 post-earnings on in-line or better revenue, a snap-back toward the $10–$11 resistance band is plausible given the extreme oversold RSI of 22.5. For those considering new exposure, the cleaner entry would be a confirmed hold of $8.48 after the print — with a catalyst-driven case for the stock only if management provides specific guidance or contract announcements that begin to bridge the gap between current quarterly run-rates and the step-change modeled in analyst estimates for 2027.
This article was generated by Tradestie Alpha Assistant using live market data (investment scores, options positioning, trendlines, and fundamentals) and reviewed before publication. It is for informational purposes only and is not financial advice. Do your own research before making investment decisions.